Legal Representation
Attorney
Carissa L. Rodrigue
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 12, 2025 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Sep 2, 2025 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Mar 1, 2025 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jan 31, 2025 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jan 31, 2025 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jul 24, 2024 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 24, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jul 24, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 23, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 23, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 23, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 23, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Apr 23, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Jan 23, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 23, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 23, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 23, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 25, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| May 24, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 1, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for therapeutic and prophylactic use for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for use in antibacterial treatments, anti-toxin treatments, anti-fungal treatments, anti-yeast treatments, anti-parasite treatments, anti-cytokine treatments, anti-receptor treatments, antibiotic treatments and antiviral treatments, for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for repairing, modifying and modulating the intestinal microbiome; all of the foregoing excluding vaccines.
Additional Information
Design Mark
The mark consists of a stylized design of the letter "Y" within a circle above the words "PRODIGY BIOTECH" in stylized letters.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOTECH"